Hammond E H, Flinner R L
Department of Pathology, LDS Hospital, Salt Lake City, UT 84143, USA.
Arch Pathol Lab Med. 1997 Nov;121(11):1171-5.
Breast cancer reports form an important part of the basis of clinical decision making for patients. Our objectives were to improve breast cancer reporting in the Urban Central Region in Utah of Intermountain Health Care in a clinically relevant manner and to show that the method chosen actually improved information transfer among physicians of breast cancer patients and led to durable changes in pathologist behavior. METHODS/INTERVENTION: Pathologists designed a synoptic report based on interviews with oncologists about what data were meaningful. The report format was piloted with one hospital pathology group, modified, and implemented in three hospitals. A report evaluation of missing information was done before, immediately after, and 2 years after the intervention. Oncologists were surveyed after 2 years to evaluate satisfaction with report format.
Changing breast cancer reporting to a synoptic format significantly decreased information missing from pathology reports. Prior to implementation, 32 of 365 reports lacked some item(s) of pathology information desirable to clinicians; after the intervention, 8 of 250 reports contained missing information. After 2 years, 1 in 190 reports contained missing data elements. Synoptic breast cancer reports continued to be used by pathologists throughout the reporting period. Oncologists responding to a survey reported uniform satisfaction with the new reporting format.
Pathologists are important members of the clinical oncology team. They provide patient-specific information crucial to patient care. Activities designed to improve the quality of reporting processes should use clinically relevant indicators of process improvement, such as measurement of missing information and satisfaction of clinical colleagues with format/quality of information.
乳腺癌报告是患者临床决策依据的重要组成部分。我们的目标是以临床相关的方式改善山间医疗保健公司犹他州城市中心地区的乳腺癌报告,并证明所选择的方法实际上改善了乳腺癌患者医生之间的信息传递,并导致病理学家行为的持久改变。方法/干预措施:病理学家在与肿瘤学家就哪些数据有意义进行访谈的基础上设计了一份概要报告。该报告格式在一个医院病理组进行了试点,经过修改后在三家医院实施。在干预前、干预后立即以及干预后2年对缺失信息进行报告评估。2年后对肿瘤学家进行调查,以评估他们对报告格式的满意度。
将乳腺癌报告改为概要格式显著减少了病理报告中缺失的信息。实施前,365份报告中有32份缺少临床医生所需的某些病理信息项目;干预后,250份报告中有8份包含缺失信息。2年后,190份报告中有1份包含缺失的数据元素。在整个报告期内,病理学家持续使用乳腺癌概要报告。参与调查的肿瘤学家对新报告格式表示一致满意。
病理学家是临床肿瘤学团队的重要成员。他们提供对患者护理至关重要的特定患者信息。旨在提高报告流程质量的活动应使用临床相关的流程改进指标,例如对缺失信息的测量以及临床同事对信息格式/质量的满意度。